| Target Price | $306.00 |
| Price | $287.42 |
| Potential | 6.46% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Travelers 2026 . The average Travelers target price is $306.00. This is 6.46% higher than the current stock price. The highest price target is $338.10 17.63% , the lowest is $236.90 17.58% . | |
| A rating was issued by 30 analysts: 12 Analysts recommend Travelers to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2026 of 6.46% . Most analysts recommend the Travelers stock at Hold. |
19 Analysts have issued a sales forecast Travelers 2025 . The average Travelers sales estimate is $45.0b . This is 7.03% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $47.1b 2.64% , the lowest is $43.5b 10.16% .
This results in the following potential growth metrics:
| 2024 | $46.4b | 12.23% |
|---|---|---|
| 2025 | $45.0b | 3.06% |
| 2026 | $46.2b | 2.60% |
| 2027 | $47.8b | 3.59% |
| 2028 | $50.7b | 5.97% |
| 2029 | $52.3b | 3.09% |
2 Analysts have issued an Travelers EBITDA forecast 2025. The average Travelers EBITDA estimate is $7.4b . This is 52.72% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.7b 50.85% , the lowest is $7.2b 54.13% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $14.3b | 33.28% |
|---|---|---|
| 2025 | $7.4b | 48.27% |
| 2026 | $8.7b | 18.30% |
| 2027 | $7.9b | 9.56% |
| 2024 | 30.74% | 18.75% |
|---|---|---|
| 2025 | 16.40% | 46.65% |
| 2026 | 18.91% | 15.30% |
| 2027 | 16.51% | 12.69% |
26 Travelers Analysts have issued a net profit forecast 2025. The average Travelers net profit estimate is $5.7b . This is 2.64% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $6.1b 4.33% , the lowest is $5.4b 6.98% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $5.0b | 67.09% |
|---|---|---|
| 2025 | $5.7b | 14.44% |
| 2026 | $6.0b | 5.92% |
| 2027 | $6.3b | 4.17% |
| 2028 | $4.8b | 24.06% |
| 2029 | $5.5b | 15.29% |
| 2024 | 10.69% | 48.88% |
|---|---|---|
| 2025 | 12.62% | 18.09% |
| 2026 | 13.02% | 3.17% |
| 2027 | 13.10% | 0.61% |
| 2028 | 9.38% | 28.40% |
| 2029 | 10.50% | 11.94% |
26 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is $25.46 . This is 0.66% lower than earnings per share in the financial year 2024. The highest EPS forecast is $27.28 6.44% , the lowest is $24.32 5.11% .
This results in the following potential growth metrics and future valuations:
| 2024 | $21.47 | 67.87% |
|---|---|---|
| 2025 | $25.46 | 18.58% |
| 2026 | $26.96 | 5.89% |
| 2027 | $28.09 | 4.19% |
| 2028 | $21.33 | 24.07% |
| 2029 | $24.59 | 15.28% |
| Current | 11.21 | 14.70% |
|---|---|---|
| 2025 | 11.29 | 0.68% |
| 2026 | 10.66 | 5.58% |
| 2027 | 10.23 | 4.03% |
| 2028 | 13.47 | 31.67% |
| 2029 | 11.69 | 13.21% |
Based on analysts' sales estimates for 2025, the Travelers stock is valued at an EV/Sales of 1.63 and an P/S ratio of 1.42 .
This results in the following potential growth metrics and future valuations:
| Current | 1.52 | 4.11% |
|---|---|---|
| 2025 | 1.63 | 7.28% |
| 2026 | 1.59 | 2.53% |
| 2027 | 1.53 | 3.47% |
| 2028 | 1.45 | 5.64% |
| 2029 | 1.40 | 3.00% |
| Current | 1.32 | 2.99% |
|---|---|---|
| 2025 | 1.42 | 7.57% |
| 2026 | 1.39 | 2.53% |
| 2027 | 1.34 | 3.47% |
| 2028 | 1.26 | 5.63% |
| 2029 | 1.23 | 3.00% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Oct 20 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 17 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 17 2025 |
| JP Morgan |
Underweight
➜
Underweight
|
Unchanged | Oct 09 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 08 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 08 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Oct 20 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 17 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 17 2025 |
|
Unchanged
JP Morgan:
Underweight
➜
Underweight
|
Oct 09 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 08 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 08 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


